Navigation Links
DURECT and Nycomed Amend POSIDUR(TM) License Agreement to Separate Funding and Control of U.S. and E.U. Clinical Programs and to Expand Territory
Date:2/22/2010

"Nycomed has been a strong partner for DURECT since the inception of our relationship, and the early portions of the U.S. and E.U. development programs have benefited from the joint guidance and co-funding by the parties. However, at this later stage of development, given the divergence between the clinical development programs required for regulatory approval as between the U.S. and E.U., and our aspirations to partner POSIDUR in the U.S., this amendment provides greater flexibility for both parties in their respective territories while at the same time preserving the close cooperation and sharing of data for our mutual benefit," stated James E. Brown, President and CEO of DURECT Corporation. "We also believe that Nycomed will diligently exploit the additional countries granted to them, from which we will benefit under the same favorable commercial terms as in our original agreement."

DURECT recently commenced BESST (Bupivacaine Effectiveness and Safety in SABER™ Trial), which is intended to be the pivotal Phase III clinical trial in the U.S. In Europe, Nycomed is currently conducting two Phase IIb clinical trials (in hysterectomy and in shoulder surgery) with OPTESIA™.

About the DURECT / Nycomed Collaboration


'/>"/>
SOURCE DURECT Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. DURECT Corporation Invites You to Join Its Fourth Quarter 2009 Earnings Conference Call
2. DURECT to Present at the 21st Annual Piper Jaffray Health Care Conference
3. DURECT Corporation Invites You to Join its Third Quarter 2009 Earnings Conference Call
4. DURECT Reports Positive Phase IIb Data from TRANSDU(TM)-Sufentanil Clinical Program
5. ELADUR(TM) Development Update: DURECT Receives Orphan Drug Designation for Bupivacaine for Post-Herpetic Neuralgia
6. DURECT Announces Positive ELADUR(TM) Phase IIa Study Results
7. Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases
8. KV Pharmaceutical Amends Agreement to Secure Rights to Gestiva(TM)
9. RetireSafe Announces Intention to Key Vote Senator Dorgans Drug Importation Amendment (SA 2793)
10. Vermillion Files Amended Plan of Reorganization and Exchanges Debt
11. RetireSafe Urges Senate to Defeat Senate Amendment 2793 -- Says Senator Dorgans Drug Importation Plan Puts Seniors at Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... -- Future Prospects for Companies in Antihistamines, ... drugs - new study showing you trends, partnerships, ... for allergic rhinitis drugs heading? What are the commercial ... shows you potential revenues and other trends to 2025, ... page report provides 273 tables, charts, and graphs. Discover ...
(Date:9/4/2015)... , Sep. 04, 2015 ... the addition of the "Stability Testing of Pharmaceuticals ... their offering. By attending this comprehensive two ... to design efficient stability studies that are suitable for ... appropriate stability studies and manage stability samples and facilities ...
(Date:9/3/2015)... , Sept. 3, 2015 ... of New Drugs, Industry Changes and Emerging Opportunities ... human ovaries? Visiongain,s new study forecasts those pharmaceutical ... in that industry. You also explore trends, results, ... Our report gives revenue predictions to 2025 at ...
Breaking Medicine Technology:Allergic Rhinitis Drugs Market Forecast 2015-2025 2Allergic Rhinitis Drugs Market Forecast 2015-2025 3Allergic Rhinitis Drugs Market Forecast 2015-2025 4Allergic Rhinitis Drugs Market Forecast 2015-2025 5Allergic Rhinitis Drugs Market Forecast 2015-2025 6Allergic Rhinitis Drugs Market Forecast 2015-2025 7Stability Testing of Pharmaceuticals: 2 Day Seminar - London, UK - December 2-3, 2015 2Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 2Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 3Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 4Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 5Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 6
... Kessler Foundation ( www.kesslerfoundation.org ) and Kessler Institute ... rehabilitation centers in the U.S. to implement the ... designed to improve mobility in individuals with  spinal ... other neurological diseases. This new system, developed by ...
... Company (NYSE: LLY ) announced that it has ... The donation will enable expansion of the foundation,s patient services ... support of a new fund for patients with nonsquamous non-small ... cancer.   PAF is a national, non-profit organization ...
Cached Medicine Technology:Kessler is the First Rehabilitation Center in the Nation to Use New Robotic Gait Training System 2Kessler is the First Rehabilitation Center in the Nation to Use New Robotic Gait Training System 3Lilly Donation to Patient Advocate Foundation Expands Services and Access for Patients With Most Common Form of Lung Cancer 2Lilly Donation to Patient Advocate Foundation Expands Services and Access for Patients With Most Common Form of Lung Cancer 3
(Date:9/4/2015)... ... ... IVF New England, one of the largest and most successful fertility centers in the ... who wish to learn more about their fertility and egg freezing. , Date and ... Manchester, NH from 6PM to 7PM , This hip, casual and informative event will ...
(Date:9/4/2015)... ... September 04, 2015 , ... Scalability Experts (SE) announced ... awards at this year’s Microsoft Worldwide Partner Conference that was held in Orlando, ... Award Winner for Data Platform services, the 2015 HP and Microsoft “Outstanding Frontline ...
(Date:9/4/2015)... ... ... Many consumers are looking for a quick and convenient way to produce a hot remedy ... Cups provide a quick and simple way to brew a hot cup of cold remedy ... a result, they enhance comfort and health. The invention features a novel design that is ...
(Date:9/4/2015)... ... September 04, 2015 , ... ... its first neighborhood created specifically for adults with intellectual, developmental and acquired disabilities. ... area and feature 30 cottage or “pocket” homes. In this community, adults will ...
(Date:9/4/2015)... ... September 04, 2015 , ... ... a Labor Day offer that cannot be passed up. FiltersFast.com, will ship ... necessary air and water filtration product replacements. Take advantage of this promotion now ...
Breaking Medicine News(10 mins):Health News:IVF New England to Host ManchVegas New Hampshire Fertility Happy Hour on October 15, 2015 in Manchester for Women Who Wish to Learn More About Fertility and Egg Freezing 2Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 2Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 3Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 4Health News:Redesigned Packaging for Powdered Medicinal Mix Invented by InventHelp® Client (CBA-2637) 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 4Health News:FiltersFast.com Wows with a Long Labor Day Weekend Shipping Offer 2
... The Department of Health and Human Services recently awarded ... for achieving a lifesaving organ donation conversion rate of ... The award was given during the fourth National ... "Everyday, the doctors, nurses and staff at Jefferson Hospital ...
... cells of the connective tissue", whose activation exacerbates allergic ... of innate immunity as well as modulators of adaptive ... gastrointestinal mucosa is not only to react to antigens, ... properties of the intestinal epithelium. In clinical studies, it ...
... injury caused by ischemia/reperfusion (I/R) has been proposed ... transplantation and major liver surgery. The production of ... and hydroxyl radical, has been demonstrated in reperfusion ... biologic effects such as a potent antioxidative effect ...
... grow human blood platelets in the laboratory for transfusion, ... University Medical Center. , The findings, published in the ... Hematology , might one day enable blood banks to ... the chronically tight supply of these critical blood components. ...
... 2 dozen contain dangerous ingredients not listed on label ... Food and Drug Administration warned consumers Monday to avoid ... because they contain undeclared ingredients that could pose serious ... retail stores and on the Internet and some claim ...
... to protect the animals from smoke,s harmful effects, researchers ... experiments in mice, scientists have shown that a new ... caused by cigarettes. , The finding holds out hope ... a chronic progressive lung disease involving both emphysema and ...
Cached Medicine News:Health News:Jefferson Hospital for Neuroscience receives Department of Health and Human Services award 2Health News:What is the effect of fluoxetine on mast cell? 2Health News:Bioreactors might solve blood-platelet supply problems 2Health News:FDA Warns About Weight Loss Products 2Health News:FDA Warns About Weight Loss Products 3Health News:Drug Shields Mice From Emphysema 2
... Recommended for aqueous samples of moderate viscosity and density. Proven ergonomic ... greasing. Volume Range (ul) ... 2~5 Imprecision(%) ... Precision (ul) ...
... Finnpipette Digital offers improved ergonomics for ... handle, modified grippy finger rest and ... comfort and efficiency. Finnpipette Digitals also ... gearing mechanism (pat. pend.) and super ...
... Pipetman Ultra is a fully adjustable, air-displacement ... It is the latest member of the ... characteristics: robustness, accuracy, and precision. We also ... feedback from our customers. Eight models cover ...
Developed specifically for the 5000/5500 ultrasound consoles....
Medicine Products: